New hope for chinese kids with rare hodgkin lymphoma
NCT ID NCT04726501
First seen Mar 21, 2026 · Last updated May 20, 2026 · Updated 12 times
Summary
This study tests a treatment plan from the U.S. on 200 Chinese children and teens with newly diagnosed Hodgkin lymphoma. The goal is to see if it works as well in China, where the disease is rare and treatment options are limited. Researchers will track how long patients stay cancer-free and overall survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Nanjing Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China
Nanjing, China
-
Shanghai Children's Medical Center
Shanghai, 200127, China
-
West China Second University Hospital, Sichuan University, Chengdu, China
Chengdu, China
Conditions
Explore the condition pages connected to this study.